Aperio Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-534,986
Closed -$53.1M 2394
2019
Q3
$53.1M Buy
534,986
+4,497
+0.8% +$427K 0.21% 94
2019
Q2
$49M Buy
530,489
+38,086
+8% +$3.62M 0.2% 97
2019
Q1
$46.5M Buy
492,403
+85,908
+21% +$7.51M 0.2% 98
2018
Q4
$26.1M Sell
406,495
-48,545
-11% -$3.58M 0.13% 173
2018
Q3
$40.7M Buy
455,040
+24,872
+6% +$2.2M 0.18% 123
2018
Q2
$34.2M Buy
430,168
+8,644
+2% +$718K 0.16% 140
2018
Q1
$37.6M Sell
421,524
-43,950
-9% -$4.22M 0.19% 119
2017
Q4
$48.6M Sell
465,474
-21,384
-4% -$2.41M 0.25% 78
2017
Q3
$71M Buy
486,858
+51,892
+12% +$7.07M 0.4% 45
2017
Q2
$56.5M Buy
434,966
+35,145
+9% +$4.31M 0.35% 52
2017
Q1
$49.8M Buy
399,821
+4,203
+1% +$503K 0.34% 52
2016
Q4
$45.8M Buy
395,618
+21,908
+6% +$2.44M 0.35% 49
2016
Q3
$39.1M Buy
373,710
+3,988
+1% +$432K 0.28% 75
2016
Q2
$36.5M Buy
369,722
+25,643
+7% +$2.65M 0.29% 78
2016
Q1
$34.4M Buy
344,079
+27,660
+9% +$2.85M 0.29% 69
2015
Q4
$37.9M Buy
316,419
+8,206
+3% +$949K 0.35% 57
2015
Q3
$33.3M Buy
308,213
+27,561
+10% +$3.42M 0.34% 58
2015
Q2
$32.5M Buy
280,652
+14,742
+6% +$1.69M 0.34% 61
2015
Q1
$30.7M Buy
265,910
+23,002
+9% +$2.75M 0.34% 59
2014
Q4
$27.2M Buy
242,908
+21,693
+10% +$2.29M 0.33% 58
2014
Q3
$21M Buy
221,215
+20,773
+10% +$1.87M 0.28% 72
2014
Q2
$17.2M Buy
200,442
+7,796
+4% +$593K 0.25% 91
2014
Q1
$13.4M Buy
+192,646
New +$15.3M 0.19% 115
2013
Q4
Sell
-176,532
Closed -$14M 69
2013
Q3
$13.6M Buy
176,532
+25,058
+17% +$1.76M 0.26% 69
2013
Q2
$8.86M Buy
+151,474
New +$9.12M 0.21% 98

Other funds holding CELG

Aperio Group's CELG Position: Q4 2019 in Review

Aperio Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 534,986 shares — an estimated $53.1M sold.

Aperio Group first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $71M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Aperio Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Aperio Group sold 534,986 Celgene Corp shares in Q4 2019, an estimated $53.1M.
  • Aperio Group first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Aperio Group's Celgene Corp position peaked at $71M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.